LTFS
LFCR icon

Ladenburg Thalmann Financial Services’s Lifecore Biomedical LFCR Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-200
Closed -$3K – 5075
2017
Q3 		$3K Hold
200
– – ﹤0.01% 4575
2017
Q2 		$3K Hold
200
– – ﹤0.01% 4479
2017
Q1 		$2K Hold
200
– – ﹤0.01% 4576
2016
Q4 		$3K Buy
+200
New +$2.77K ﹤0.01% 4420

Other funds holding LFCR

NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

Ladenburg Thalmann Financial Services's LFCR Position: Q4 2017 in Review

Ladenburg Thalmann Financial Services sold out of Lifecore Biomedical (LFCR) in Q4 2017, closing a stake of 200 shares — an estimated $3K sold.

Ladenburg Thalmann Financial Services first reported a position in LFCR in Q4 2016 and held it in 4 quarters. The position peaked at $3K in Q3 2017. 91 funds tracked by Wall St. Rank hold LFCR as of Q4 2017.

  • Ladenburg Thalmann Financial Services reported no remaining Lifecore Biomedical position as of Q4 2017 after selling out during the quarter.
  • Ladenburg Thalmann Financial Services sold 200 Lifecore Biomedical shares in Q4 2017, an estimated $3K.
  • Ladenburg Thalmann Financial Services first reported a position in Lifecore Biomedical in Q4 2016 and held it in 4 quarters.
  • Ladenburg Thalmann Financial Services's Lifecore Biomedical position peaked at $3K in Q3 2017.
  • 91 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q4 2017.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2017, filed 14 Feb 2018.